A Comprehensive Digital Care Program for Migraine Management
← catalyst calendarNCT07642414 · readout ≤ 73 d
Sponsored by Hinge Health, Inc (industry) · HNGE — their whole pipeline →.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
140estimated
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Jun 2026 | estimated | When the study began enrolling |
| Primary completion | Oct 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Nov 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2026-06-11 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-16 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Migraine
- Migraine With Aura
- Migraine Without Aura
Interventions
- Device: Neuromodulation Wearable Device
- Other: Migraine Digital Care Program
Primary outcome
what the primary-completion date above is the date OFMean Change in Monthly Migraine Days (MMDs)
measured From the 28-day baseline run-in period to the final 28 days of the 12-week intervention (approximately 16 weeks total)
Permalink · HNGE's whole pipeline · Catalyst calendar · Every registered study · What changed